These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8613982)

  • 1. The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.
    Lamba D; Bauer M; Huber R; Fischer S; Rudolph R; Kohnert U; Bode W
    J Mol Biol; 1996 Apr; 258(1):117-35. PubMed ID: 8613982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic domain structure of vampire bat plasminogen activator: a molecular paradigm for proteolysis without activation cleavage.
    Renatus M; Stubbs MT; Huber R; Bringmann P; Donner P; Schleuning WD; Bode W
    Biochemistry; 1997 Nov; 36(44):13483-93. PubMed ID: 9354616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.
    Renatus M; Engh RA; Stubbs MT; Huber R; Fischer S; Kohnert U; Bode W
    EMBO J; 1997 Aug; 16(16):4797-805. PubMed ID: 9305622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kunitz-type soybean trypsin inhibitor revisited: refined structure of its complex with porcine trypsin reveals an insight into the interaction between a homologous inhibitor from Erythrina caffra and tissue-type plasminogen activator.
    Song HK; Suh SW
    J Mol Biol; 1998 Jan; 275(2):347-63. PubMed ID: 9466914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
    Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and function of human tissue-type plasminogen activator (t-PA).
    van Zonneveld AJ; Veerman H; MacDonald ME; van Mourik JA; Pannekoek H
    J Cell Biochem; 1986; 32(3):169-78. PubMed ID: 3097031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.
    Rios-Steiner JL; Schenone M; Mochalkin I; Tulinsky A; Castellino FJ
    J Mol Biol; 2001 May; 308(4):705-19. PubMed ID: 11350170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain.
    Keil C; Maskos K; Than M; Hoopes JT; Huber R; Tan F; Deddish PA; Erdös EG; Skidgel RA; Bode W
    J Mol Biol; 2007 Feb; 366(2):504-16. PubMed ID: 17157876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for substrate interactions in C5a peptidase from Streptococcus pyogenes: A 1.9 A crystal structure of the active form of ScpA.
    Kagawa TF; O'Connell MR; Mouat P; Paoli M; O'Toole PW; Cooney JC
    J Mol Biol; 2009 Feb; 386(3):754-72. PubMed ID: 19152799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refined 2.0 A X-ray crystal structure of the snake venom zinc-endopeptidase adamalysin II. Primary and tertiary structure determination, refinement, molecular structure and comparison with astacin, collagenase and thermolysin.
    Gomis-Rüth FX; Kress LF; Kellermann J; Mayr I; Lee X; Huber R; Bode W
    J Mol Biol; 1994 Jun; 239(4):513-44. PubMed ID: 8006965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human tissue-type plasminogen activator variants with amino acid mutations in the kringle 1 domain.
    Ikenaka Y; Yajima K; Yahara H; Maruyama H; Matsumoto K; Okada K; Ueshima S; Matsuo O
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):381-7. PubMed ID: 1330023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular biology of tissue-type plasminogen activator (t-PA) and clinical application of recombinant t-PA].
    Fukao H; Matsuo O
    Nihon Rinsho; 1993 Jun; 51(6):1620-6. PubMed ID: 8320841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA)--studies with active site mutagenized plasminogen and plasmin resistant t-PA.
    Lijnen HR; Van Hoef B; De Cock F; Collen D
    Thromb Haemost; 1990 Aug; 64(1):61-8. PubMed ID: 2148848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
    Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
    Anglés-Cano E; Rojas G
    Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the fibronectin finger-like domain and the kringle 1 domain.
    Yahara H; Matsumoto K; Maruyama H; Nagaoka T; Ikenaka Y; Yajima K; Fukao H; Ueshima S; Matsuo O
    Thromb Haemost; 1994 Dec; 72(6):893-9. PubMed ID: 7740460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis at Pro309 of single-chain urokinase-type plasminogen activator alters its catalytic properties.
    Sun Z; Liu JN
    Proteins; 2005 Dec; 61(4):870-7. PubMed ID: 16231330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamics of ligand binding and denaturation for His64 mutants of tissue plasminogen activator kringle-2 domain.
    Kelley RF; DeVos AM; Cleary S
    Proteins; 1991; 11(1):35-44. PubMed ID: 1961700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.